Dual PI3K Delta/Gamma Inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Dual PI3K Delta/Gamma Inhibitor, covering 2016-06-24 to 2020-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma [Phase 1]